INASL 指南在接受化疗的患者中乙型肝炎病毒感染的管理 ,生物制品,免疫抑制剂,或者皮质类固醇.
关键词: ACLF, Acute-on-Chronic Liver Failure AFP, Alphafetoprotein ALT, Alanine Aminotransferase Anti-HBc, Antibodies to Hepatitis B Core Antigen Anti-HBs, Antibodies to Hepatitis B Surface Antigen CHB, Chronic Hepatitis B CHOP, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone CKD, Chronic Kidney Disease DILI, Drug-Induced Liver Injury DNA, Deoxyribonucleic Acid ETV, Entecavir GRADE, Grading of Recommendations, Assessment, Development and Evaluation HAV, Hepatitis A Virus HBIG, Hepatitis B Immune Globulin HBV DNA, Hepatitis B Virus Deoxyribonucleic Acid HBV, Hepatitis B Virus HBcAg, Hepatitis B Core Antigen HBeAg, Hepatitis B Envelope Antigen HBsAg, Hepatitis B Surface Antigen HDV, Hepatitis D Virus HEV, Hepatitis E Virus HLA, Human Leukocyte Antigen Class I INASL, Indian National Association for Study of the Liver LAM, Lamivudine NAs, Nucleos(t)ide Analogs NHL, Non-Hodgkin’s Lymphoma NK, Natural Killer PegIFN-α, Pegylated Interferon Alpha RA, Rheumatoid Arthritis SLE, Systemic Lupus Erythematosus TAF, Tenofovir Alafenamide TDF, Tenofovir Disoproxil Fumarate TLC, Total Leucocyte Count ULN, Upper Limit of Normal cancer cccDNA, Covalently Closed Circular Deoxyribonucleic Acid chemotherapy hepatitis B immunosupressants liver failure rcDNA, Relaxed-Circular Deoxyribonucleic Acid
来 源:
DOI:10.1016/j.jceh.2018.06.010
PDF(Pubmed)